Redeye is positive about Neola Medical receiving FDA Breakthrough Device Designation for the Neola device, which we view as a significant milestone that provides further validation of the technology and strengthens the company’s US regulatory pathway. The designation also increases our confidence in our estimated US launch year and supports our current view of the regulatory timeline.
LÄS MER
